Stock 6919 CALIWAY BIOPHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Caliway Biopharmaceuticals Co., Ltd.

Equities

6919

TW0006919004

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 13/06/2024 BST 		5-day change 1st Jan Change
486 TWD +0.41% Intraday chart for Caliway Biopharmaceuticals Co., Ltd. +8.00% +154.12%
05-13 Caliway Biopharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-25 Caliway Biopharmaceuticals Co., Ltd. Announces CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CALIWAY BIOPHARMACEUTICALS CO., LTD. Stock Caliway Biopharmaceuticals Co., Ltd.
 2.09B - - - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 791B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 630B
MERCK & CO., INC. Stock Merck & Co., Inc.
 328B
ABBVIE INC. Stock AbbVie Inc.
 298B
ASTRAZENECA PLC Stock AstraZeneca PLC
 246B
  1. Stock Market
  2. Equities
  3. 6919 Stock
  4. Charts Caliway Biopharmaceuticals Co., Ltd.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW